$0.54 EPS Expected for Pennsylvania Real Estate Investment Trust (PEI); Agilent Technologies, Inc. (A) Had 3 Analysts Last Week

Pennsylvania Real Estate Investment Trust (NYSE:PEI) Logo

Analysts expect Pennsylvania Real Estate Investment Trust (NYSE:PEI) to report $0.54 EPS on February, 13.They anticipate $0.03 EPS change or 5.88% from last quarter’s $0.51 EPS. PEI’s profit would be $42.52M giving it 3.18 P/E if the $0.54 EPS is correct. After having $0.35 EPS previously, Pennsylvania Real Estate Investment Trust’s analysts see 54.29% EPS growth. The stock decreased 4.59% or $0.33 during the last trading session, reaching $6.86. About 509,191 shares traded. Pennsylvania Real Estate Investment Trust (NYSE:PEI) has declined 26.91% since January 11, 2018 and is downtrending. It has underperformed by 26.91% the S&P500. Some Historical PEI News: 29/05/2018 – PREIT Executes Successful Recast of $700 million Revolving Credit and Term Loan Facility; 04/04/2018 – PREIT Creates New Magnolia Mall Shopping Experience With Completion of Proactive Anchor Recapture; 28/03/2018 – PREIT Announces Ron Rubin Will Step Down From PREIT Board of Trustees; 18/04/2018 – PREIT – AS A RESULT OF PREIT’S DISPOSITION, STRATEGY, IT REDUCED ITS BON-TON EXPOSURE FROM 10 IN 2012 TO 2 TODAY; 03/04/2018 – PotlatchDeltic Scheduled to Release First Quarter 2018 Earnings on May 3rd; 29/05/2018 – Penn Real Estate Modifies, Extends $400 Million Unsecured Revolving Credit Facility; 02/05/2018 – Global X Company Buys New 1.4% Position in Pennsylvania REIT; 01/05/2018 – Penn Real Estate 1Q Loss/Shr 15c; 29/05/2018 – Penn Real Estate Has No Material Debt Maturities Until 2021; 05/04/2018 – Cramer also sits down with the CEOs of Ollie’s Bargain Outlet Holdings and Pennsylvania Real Estate Investment Trust

Among 3 analysts covering Agilent Technologies (NYSE:A), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Agilent Technologies had 5 analyst reports since August 15, 2018 according to SRatingsIntel. The firm has “Overweight” rating by Morgan Stanley given on Tuesday, November 20. As per Wednesday, October 10, the company rating was maintained by Morgan Stanley. The stock of Agilent Technologies, Inc. (NYSE:A) has “Buy” rating given on Wednesday, August 15 by Deutsche Bank. The firm has “Overweight” rating given on Wednesday, August 15 by Morgan Stanley. See Agilent Technologies, Inc. (NYSE:A) latest ratings:

03/01/2019 Broker: Needham Rating: Buy New Target: $77 Initiates Coverage On
20/11/2018 Broker: Morgan Stanley Old Rating: Overweight New Rating: Overweight Old Target: $86 New Target: $89 Maintain
10/10/2018 Broker: Morgan Stanley Old Rating: Overweight New Rating: Overweight Old Target: $84 New Target: $86 Maintain
15/08/2018 Broker: Deutsche Bank Old Rating: Buy New Rating: Buy Old Target: $77 New Target: $80 Maintain
15/08/2018 Broker: Morgan Stanley Old Rating: Overweight New Rating: Overweight Old Target: $83 New Target: $84 Maintain

Since September 11, 2018, it had 0 insider buys, and 6 sales for $3.85 million activity. FIELDS HEIDI sold 5,482 shares worth $371,296. 8,902 shares valued at $658,748 were sold by Grau Dominique on Monday, December 3. 1,500 Agilent Technologies, Inc. (NYSE:A) shares with value of $106,590 were sold by Gonsalves Rodney. $1.17 million worth of Agilent Technologies, Inc. (NYSE:A) shares were sold by McMullen Michael R.. Another trade for 2,876 shares valued at $197,294 was made by CLARK PAUL N on Thursday, September 13.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company has market cap of $22.17 billion. The Company’s Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; laboratory software and informatics systems; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. It has a 71.74 P/E ratio. The companyÂ’s Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment services; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients.

The stock decreased 0.44% or $0.31 during the last trading session, reaching $69.59. About 382,164 shares traded. Agilent Technologies, Inc. (NYSE:A) has risen 5.82% since January 11, 2018 and is uptrending. It has outperformed by 5.82% the S&P500. Some Historical A News: 15/05/2018 – Agilent Closes Below 50-Day Moving Average: Technicals; 14/03/2018 – Australian Gov: US Patent Issued to Agilent Technologies on March 13 for “In-source collision-induced heating and activation of; 07/03/2018 – Agilent: AATI, Based in Ankeny, Iowa, Has 101 Employee; 18/04/2018 – AGILENT FILES CIVIL SUIT VS CHANGZHOU PANNATEK; 03/04/2018 – AGILENT TECHNOLOGIES IN PACT TO BUY LASERGEN,; 07/03/2018 – Agilent to Buy Advanced Analytical Technologies for $250M Cash; 02/05/2018 – AGILENT TECHNOLOGIES TO ENHANCE LAB INFORMATICS WITH PURCHASE O; 22/05/2018 – AGILENT TECHNOLOGIES INC A.N – SIGNED A DEFINITIVE AGREEMENT TO ACQUIRE AGILENT-RELATED BUSINESS FROM YOUNG IN SCIENTIFIC CO. LTD; 16/04/2018 – AGILENT REPORTS DEPARTURE OF PATRICK KALTENBACH; 07/05/2018 – AGILENT COMPLETES PURCHASE OF LASERGEN,

Investors sentiment increased to 1.05 in Q3 2018. Its up 0.17, from 0.88 in 2018Q2. It is positive, as 36 investors sold Agilent Technologies, Inc. shares while 186 reduced holdings. 72 funds opened positions while 162 raised stakes. 255.34 million shares or 2.22% less from 261.14 million shares in 2018Q2 were reported. Oakworth accumulated 0.01% or 390 shares. Everence Mngmt holds 0.08% or 5,785 shares in its portfolio. Bluemountain Cap Mngmt Limited Liability Corporation holds 90,539 shares or 0.11% of its portfolio. Quantitative Systematic Strategies Lc reported 40,570 shares. New York State Common Retirement Fund invested in 653,200 shares or 0.05% of the stock. Citigroup accumulated 269,197 shares or 0.02% of the stock. Wealthtrust Fairport Ltd Liability Corp stated it has 0.72% of its portfolio in Agilent Technologies, Inc. (NYSE:A). California-based Lpl Financial Llc has invested 0.01% in Agilent Technologies, Inc. (NYSE:A). Employees Retirement Systems Of Ohio invested in 0.11% or 311,142 shares. Mutual Of America Capital Mngmt Lc accumulated 64,160 shares or 0.06% of the stock. 7 are held by Financial Mngmt Pro. State Of Tennessee Treasury Department holds 0.18% or 521,159 shares. Hoplite Management Ltd Partnership, a New York-based fund reported 794,370 shares. Nuveen Asset Management Ltd Limited Liability Company has 0.04% invested in Agilent Technologies, Inc. (NYSE:A). Washington National Bank & Trust reported 48 shares.

Among 2 analysts covering Pennsylvania REIT (NYSE:PEI), 0 have Buy rating, 1 Sell and 1 Hold. Therefore 0 are positive. Pennsylvania REIT had 3 analyst reports since August 16, 2018 according to SRatingsIntel. The firm earned “Neutral” rating on Tuesday, November 6 by Citigroup. The firm has “Neutral” rating given on Thursday, August 16 by Citigroup. The rating was downgraded by JP Morgan to “Underweight” on Wednesday, December 19.

Investors sentiment decreased to 0.75 in Q3 2018. Its down 0.56, from 1.31 in 2018Q2. It is negative, as 27 investors sold Pennsylvania Real Estate Investment Trust shares while 61 reduced holdings. 27 funds opened positions while 39 raised stakes. 60.08 million shares or 1.42% less from 60.94 million shares in 2018Q2 were reported. 369,548 were reported by Ameriprise Fincl Inc. Schwab Charles Investment holds 1.38M shares or 0.01% of its portfolio. Mirae Asset Glob Limited holds 987,791 shares. Ny State Common Retirement Fund reported 0% of its portfolio in Pennsylvania Real Estate Investment Trust (NYSE:PEI). Wells Fargo And Co Mn holds 233,109 shares or 0% of its portfolio. Brown Brothers Harriman & stated it has 28,128 shares or 0% of all its holdings. First National Tru owns 16,250 shares for 0.02% of their portfolio. Us Bancorp De reported 23,565 shares stake. Geode Cap Mgmt reported 845,559 shares. Barclays Public Ltd Co reported 209,130 shares. Meeder Asset Management, a Ohio-based fund reported 7,405 shares. Veritable Limited Partnership reported 190,078 shares or 0.04% of all its holdings. Signaturefd Ltd Liability holds 94 shares. Illinois-based Wolverine Asset Mgmt Limited Liability has invested 0.03% in Pennsylvania Real Estate Investment Trust (NYSE:PEI). Bluecrest Management Ltd accumulated 0.01% or 37,817 shares.

Pennsylvania Real Estate Investment Trust (NYSE:PEI) Institutional Positions Chart